Rick Scalzo
Director of Finance/CFO at DYNE THERAPEUTICS, INC.
Net worth: 4 M $ as of 2024-05-30
Rick Scalzo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DYNE THERAPEUTICS, INC. | Chief Administrative Officer | 2020-06-30 | - |
| Director of Finance/CFO | 2020-06-30 | - | |
| Treasurer | 2020-06-30 | 2020-07-01 |
Career history of Rick Scalzo
Former positions of Rick Scalzo
| Companies | Position | Start | End |
|---|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 2018-07-31 | 2019-11-28 |
| X4 PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2016-08-31 | 2018-07-31 |
| OCATA THERAPEUTICS INC | Comptroller/Controller/Auditor | 2014-07-31 | 2014-08-31 |
Training of Rick Scalzo
| University of Massachusetts | Masters Business Admin |
| Boston College | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Comptroller/Controller/Auditor | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
- Stock Market
- Insiders
- Rick Scalzo
- Experience
